Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-04-13 12:52 (1997 d 18:07 ago) – Posting: # 18679
Views: 2,527

Dear All,

Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT (oral Dispersible Tablet) BE study. Could any one please suggest the drug administration procedure for oral Dispersible Tablet in bioequivalence study (If product specific BE study recommendation not issued).



Complete thread:

UA Flag
 Admin contact
22,763 posts in 4,775 threads, 1,628 registered users;
9 visitors (0 registered, 9 guests [including 2 identified bots]).
Forum time: 06:59 CEST (Europe/Vienna)

The object of statistics is information.
The objective of statistics is the understanding of information
contained in data.    Irwin and Marylees Miller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz